FJFeng Jia

Feng Jia

*This is an algorithmically generated author record based on publicly available information.

Feng Jia has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Weakened and Imbalanced Gene Expression of Rheumatoid Arthritis Patients with Qi-Blood-Deficiency Syndrome

    by Guang Zheng, Feng Jia, Siyu Wang, Hongtao Guo

    Exploring the gene expression profile of rheumatoid arthritis (RA) patients with qi-blood-deficiency syndrome may shed light on the pathology of RA patients with qi-blood-deficiency syndrome in traditional Chinese medicine (TCM) towards precision medicine. In this study, GWAS (genome-wide association study), enrichment analysis, and visualizations were deployed on GSE205962 containing samples of RA patients with qi-blood-deficiency syndrome compared with healthy ones. As a result, more than half of differentially expressed genes were weakened/inhibited in RA patients with qi-blood-deficiency syndrome. To be enriched and demonstrated in KEGG RA-associated pathways, these pathways are all weakened and imbalanced with three gene groups: the activated, the inhibited, and the normal group. Besides, enrichment analysis also demonstrated that many signaling pathways are weakened and imbalanced by the development of RA with qi-blood-deficiency syndrome.

  • Open Access

    In vitro and in vivo superior radiosensitizing effect of berbamine for head and neck squamous cell carcinoma

    by Hongmei Zhu, Shu Ruan, Feng Jia, Jiusheng Chu, Yong Zhu, Yongjiu Huang, Guan Liu

    Background: Berbamine (BBM), one of the bis-benzylisoquinoline products isolated from Berberis amurensis, has been demonstrated for its anticancer effect against leukemia, breast cancer, liver cancer, etc. There are some studies focusing on the chemosensitization effect of BBM. However, there is no report about whether BBM could enhance the anticancer effect of radiation, which made us to explore the possible radiosensitization effect of BBM. Materials and methods: Here, in vitro cytotoxicity of BBM was evaluated on two kinds of head and neck squamous cancer cell lines. Clonogenic assay was performed to study the radiosensitization effect of BBM. Western blot was utilized to elucidate the possible mechanism underlying the radiosensitization effect. Results: BBM effectively inhibited the growth of two kinds of cancer cells in a time- and dose-dependent manner. Radiation plus BBM led to significantly more reduction of the colony-forming ability of cancer cells when compared with radiation alone. BBM plus radiation led to the most reduction of STAT3 phosphorylation, followed by the significant decrease of the ratio of Bax/Bcl-2. In vivo study demonstrated that the combinational administration of BBM and radiation generated the most significant tumor-delaying effect among all of the treatment regimens. Conclusion: We reported, in the current study, the potential role of BBM in not only treating cancer by itself but also offering a promising way to improve the efficacy of radiotherapy by inhibiting the activation of STAT3 and subsequently inducing the apoptosis of cancer.


  • Open Access

    Synergistic Antitumor Effects of Berbamine and Paclitaxel through ROS/Akt Pathway in Glioma Cells

    by Feng Jia, Shu Ruan, Ning Liu, Linshan Fu

    In our preliminary study, Berbamine (BA), one of the most commonly used traditional Chinese medicines, was effective in inducing the intracellular ROS levels. Since the regulation of cellular antioxidant capacity is crucial to the sensitivity of Ptx, it is feasible to propose that sensitizing cells to Ptx can be achieved through increasing the antioxidant capacity by codelivering BA. Cytotoxicity test demonstrates that either single or combinational treatment of BA and Ptx dose‐dependently inhibits the proliferation of U‐87 cells. Median‐effect analysis clearly proves the synergistic anticancer effect between BA and Ptx. Combinational treatment of both drugs induced more intracellular ROS generation than either of the drugs did. Cotreatment of NAC could partially reverse the ROS generation and ameliorate the cytotoxicity induced by BA plus Ptx. Moreover, sequential activation of ROS‐dependent phosphor‐Akt expression was dose‐dependently inhibited by the combinational application of BA and Ptx, which was more significantly effective than the single treatment of either BA or Ptx. Additionally, the coadministration of BA and Ptx shows the strongest tumor delaying effect in a U87 xenograft model, demonstrating the synergism between two drugs. Therefore, BA is a promising adjuvant to traditional chemotherapy, especially in combination with Ptx, to treat malignant glioma.


  • Open Access

    Potential Antitumor Effect of Harmine in the Treatment of Thyroid Cancer

    by Shu Ruan, Feng Jia, Jianbo Li

    Thyroid cancer is one of the most common types of cancer in endocrine system. In latest studies, harmine has been proved to inhibit the growth of several cancers in vitro and in vivo. In the current study, we evaluated the in vitro and in vivo anticancer efficiency of harmine against thyroid cancer cell line TPC‐1. The in vitro cytotoxicity of harmine evaluated by XTT assay indicated that harmine suppressed the proliferation of TPC‐1 cells in a dose‐ and time‐dependent manner. Moreover, harmine dose‐dependently induced apoptosis of TPC‐1 cells through regulating the ratio of Bcl‐2/Bax. The colony forming ability of TPC‐1 cells was also time‐dependently inhibited by harmine. The inhibitory effects of harmine on migration and invasion of TPC‐1 cells were studied by wound scratching and Transwell assays. In vivo evaluation showed that harmine effectively inhibited the growth of thyroid cancer in a dose‐dependent manner in nude mice. Therefore, harmine might be a promising herbal medicine in the therapy of thyroid cancer and further efforts are needed to explore this therapeutic strategy.